NCT06879821 High-intensity Functional Training on Functional and Cognitive Performance in People with Parkinson's Disease.
| NCT ID | NCT06879821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundacion Para La Investigacion Hospital La Fe |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 34 participants |
| Start Date | 2022-03-14 |
| Primary Completion | 2022-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 34 participants in total. It began in 2022-03-14 with a primary completion date of 2022-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Parkinson's disease (PD) is a progressive and chronic neurodegenerative disease, which presents signs and symptoms both motor (impaired gait, posture, balance, etc.) and cognitive (memory loss, dementia, etc.), all of which are causing disability and assuming a high economic cost. Currently, there are already certain authors who have shown how a high-intensity interval training (HIIT) protocol produces improvements in cognitive and physical performance in healthy adults6 and in people with multiple sclerosis. However, another modality has been created, such as high-intensity functional training (HIFT), which can benefit different populations, both healthy and pathological, due to the multimodal nature of the exercises. Thanks to multimodality, more aspects such as agility, coordination and precision of movements are worked on compared to unimodal HIIT programs that make this relevant work difficult in a person's daily life. The current study aims to demonstrate the effectiveness of a HIFT training protocol in a specific population, such as people with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Parkinson's disease. * Stage I or II (Hoehn - Yahr Scale). * Age between 45 and 80 years. * Independent ambulation for 10 consecutive minutes. * Regular physical exercise. Exclusion Criteria: * Medical contraindication for physical activity, deafness or limited hearing and very low vision or blind. * Vestibular disorders that compromise balance. * Psychotic or severe cognitive disorder. * Decompensation or changes in medication. * Surgical intervention in the last 6 months. * Sedentary persons
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06879821 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06879821 currently recruiting?
Yes, NCT06879821 is actively recruiting participants. Contact the research team at marta.aguilar@uv.es for enrollment information.
Where is the NCT06879821 trial being conducted?
This trial is being conducted at Valencia, Spain.
Who is sponsoring the NCT06879821 clinical trial?
NCT06879821 is sponsored by Fundacion Para La Investigacion Hospital La Fe. The trial plans to enroll 34 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.